ClinicalTrials.Veeva

Menu

An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell Carcinoma

G

Guangzhou Institute of Respiratory Disease

Status

Not yet enrolling

Conditions

Squamous Cell Carcinoma of Esophagus

Study type

Observational

Funder types

Other

Identifiers

NCT05759325
ESCC ctDNA-MRD

Details and patient eligibility

About

The purpose of this study is to observe and evaluate the correlation between ctDNA-MRD and the therapeutic effect and prognosis of stage II-IVA operable esophageal squamous cell carcinoma.

Full description

ESCC patients with II-IVA resection will undergo MRD examination at the following time: the first examination is before the operation, the second examination is 7-10 days after the operation, and then 1 month after the operation, 2 weeks after the end of adjuvant treatment (if available), the follow-up period (every 3 months if there is no postoperative treatment) and the progress (the progress of the disease confirmed by the researcher), the patients will receive close MRD monitoring to evaluate the correlation between ctDNA-MRD and therapeutic efficacy and prognosis.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients with stage II-IVA Esophageal squamous cell carcinoma confirmed by clinical pathological staging;
  2. ≥18 years;
  3. Eastern Cooperative Oncology Group performance status score (ECOG PS) is 0 ~ 1 points;
  4. Expected survival time ≥ 6 months;
  5. Patients agree and have the ability to follow the planned study visits, laboratory tests and other research steps.

Exclusion criteria

  1. Patients with other malignant tumors;
  2. Patient had undergone surgery before admission;
  3. Pregnant or lactating women;
  4. Patients with other serious diseases;
  5. Patients who could not understand the experiment content and could not cooperate with them and refused to sign the informed consent form;
  6. Patients with contraindications to radiotherapy and chemotherapy;
  7. Other researchers think it is not suitable.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems